Volume: 22 Issue: 3

1. Pharmacological and Safety Profile of Dexlansoprazole: A New Proton Pump Inhibitor - Implications for Treatment of Gastroesophageal Reflux Disease in the Asia Pacific Region. Page:355—366
2. Stem Cells in the Intestine: Possible Roles in Pathogenesis of Irritable Bowel Syndrome. Page:367—382
3. Use of Prucalopride for Chronic Constipation: A Systematic Review and Meta-analysis of Published Randomized, Controlled Trials. Page:412—422
4. Diagnosis and Treatment of Dyssynergic Defecation. Page:423—435
5. Esophageal Submucosal Injection of Capsaicin but Not Acid Induces Symptoms in Normal Subjects. Page:436—443
6. Laryngopharyngeal Reflux in Children with Chronic Otitis Media with Effusion. Page:452—458
7. Analysis of Gastric and Duodenal Eosinophils in Children with Abdominal Pain Related Functional Gastrointestinal Disorders According to Rome III Criteria. Page:459—469
8. Sphincter of Oddi Manometry: Reproducibility of Measurements and Effect of Sphincterotomy in the EPISOD Study. Page:477—482
9. Value of 24-hour Delayed Film of Barium Enema for Evaluation of Colon Transit Function in Young Children with Constipation. Page:483—489
10. Efficacy of Cranial Electrotherapy Stimulation Combined with Biofeedback Therapy in Patients with Functional Constipation. Page:497—508
11. Clinical Dimensions of Bloating in Functional Gastrointestinal Disorders. Page:509—516
12. Erythromycin Induced Nightmares. Page:539—540
13. Sphincter of Oddi Manometry: Methodological Issues in Reproducibility of Measurements. Page:541—541
14. Clinical Manifestations of Laryngopharyngeal Reflux. Page:351—352
15. The Gastric and Duodenal Eosinophilia in Functional Dyspepsia. Page:353—354
16. Guidelines for the Diagnosis and Treatment of Chronic Functional Constipation in Korea, 2015 Revised Edition. Page:383—411
17. Protective Effect of Proton Pump Inhibitor for Survival in Patients with Gastroesophageal Reflux Disease and Idiopathic Pulmonary Fibrosis. Page:444—451
18. Impaired Gallbladder Motility and Increased Gallbladder Wall Thickness in Patients with Nonalcoholic Fatty Liver Disease. Page:470—476
19. Long-term Clinical Course of Post-infectious Irritable Bowel Syndrome After Shigellosis: A 10-year Follow-up Study. Page:490—496
20. Neurotensin Changes Propulsive Activity into a Segmental Motor Pattern in the Rat Colon. Page:517—528
21. The Effect of DA-9701 in Opioid-induced Bowel Dysfunction of Guinea Pig. Page:529—538
22. Probiotic Yeast Therapy for Irritable Bowel Syndrome. Page:542—542
23. Probiotic Yeast Therapy for Irritable Bowel Syndrome. Page:542—542
24. Sphincter of Oddi Manometry: Methodological Issues in Reproducibility of Measurements. Page:541—541